ROYALTY PHARMA PLC- CL A (RPRX)       42.87  -0.11 (-0.26%)

42.87  -0.11 (-0.26%)

GB00BMVP7Y09 - Common Stock - After market: 42.87 0 (0%)

Buy % Consensus

81
Analysts have set a mean price target of 55.4. This target is 29.22% above the current price.
RPRX was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RPRX.
In the previous month the buy percentage consensus was at a similar level.
RPRX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 42.8749.8956.1055.4063.00 - 16.38% 30.86% 29.22% 46.96%

Up and Down Grades

Date Firm Action Rating
2022-11-09 Morgan Stanley Maintains Overweight
2022-10-18 JP Morgan Maintains Overweight
2022-08-08 Morgan Stanley Maintains Overweight
2022-07-14 Tigress Financial Maintains Buy
2022-06-14 UBS Initiate Buy
2022-05-13 ScotiaBank Initiate Outperform
2022-04-27 Goldman Sachs Initiate Buy
2022-04-14 JP Morgan Upgrade Neutral -> Overweight
2021-10-29 Citigroup Upgrade Neutral -> Buy
2021-08-16 Morgan Stanley Maintains Equal-Weight
2021-07-30 Tigress Financial Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA